Quality of life in patients treated for end-stage renal failure;La qualite de vie des patients traites pour insuffisance renale chronique terminale

Presse Medicale

Volumn 27, Issue 29, 1998, Pages 1499-1505

  Patte, D ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

DISEASE ASSOCIATION; KIDNEY FAILURE; LIFE EXPECTANCY; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; ADULT; AGE; AGED; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; HOME DIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MIDDLE AGED; PERITONEAL DIALYSIS; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; SOCIOECONOMICS; TERMINAL CARE; TIME;

ADULT; AGE FACTORS; AGED; COST-BENEFIT ANALYSIS; ERYTHROPOIETIN, RECOMBINANT; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; RENAL DIALYSIS; SOCIOECONOMIC FACTORS; TERMINAL CARE; TIME FACTORS;

EID: 2442640879     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Launois R, Regnier F. Décision thérapeutique et qualité de vie. John Libbey Eurotext Paris 1992.
2. Jasmin C, Levy JA, Bez G. La qualité de vie. Synthelabo Groupe Paris 1996.
3. Landsman M. The patient with chronic renal failure : a marginal man. Ann Intern Med 1975 ; 82:268-70.
4. Gutman RA, Stead NW, Robinson RR. Physical activity and employment status of patients on maintenance dialysis. N Engl J Med 1981 ; 304:309-13.
5. Simmons RG, Anderson A, Kamsha L. Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis and after transplantation. Am J Kidney Dis 1984 ; 4:253-5.
6. Evans RW, Manninen DL, Garrison L.P. et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985 ; 312:553-9.
7. Bremer BA, Mc Cauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease : a reexamination. Am J Kidney Dis 1989 ; 13:200-9.
8. Morris P.L., Jones B. Transplantation versus dialysis : a study of quality of life. Transplant Proc 1988 ; 20:23-6.
9. Wolcott DL, Nissenson AR. Quality of life in chronic dialysis patients : a critical comparison of CAPD and HD. Am J Kidney Dis 1989 ; 13:200-9.
10. Park JH, Yoo HJ, Han DJ et al. Changes in the quality of life before and after renal transplantation and comparison of the quality of life between transplant recipients, dialysis patients, and normal controls. Transplant Proc 1996 ; 28:1937-8.
11. Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int 1992 ; 43 (suppl 40):23-7.
12. De Vecchi AF, Scalomogna A, Colombini M et al. Well being in patients on CAPD and hemodialysis. Int J Artif Organs 1994 ; 17:473-7.
13. Moreno F, Lopez Gomez JM, Sanz-Guasardo D, Joffre R, Valderrabano F. Quality of life in dialysis patients. A Spanish multicentre study. Nephrol Dial Transplant 1996 ; 11 (suppl 2): 125-9.
14. Evans RW, Rader B, Manninen DL and Cooperative multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human Erythropoietin. J Am Med Assoc 1990 ; 263: 825-30.
15. Canadian Erythropoietin Study Group/Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receving haemodialysis. Br Med J 1990 ; 300:573-8.
16. Barany P, Petterson E, Konarski-Svensson JK. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with Erythropoietin. Nephrol Dial Transpl 1993 ; 8:426-32.
17. Moreno F, Aracil FJ, Perez R, Valderrabano F. Controled study on the improvement of quality of life in elderly hemodialysis patients after correcting end stage renal disease - related anemia with Erythropoietin. Am J Kidney Dis 1996 ; 27:548-56.
18. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE. Jr The effects of recombinant human Erythropoïetin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996 ; 7:763-73.
19. Westlie L, Umen A, Nestrud S, Kjellstrand CM. Mortality, morbidity and life satisfaction in the very old dialysis patient. Trans Am S Artif Intern Organs 1984 ; 30:21-30.
20. Friedman EA. Outcome and complications of chronic hemodialysis. In: Diseases of the kidney, Schrier RW Gottschalk CW eds. Little Brown et Co. Toronto 1988.
21. Jacobs C Insuffisance rénale chronique terminate : traitement par les méthodes de dialyse. Acquisitions et controverses après 35 années d'expérience. Presse Med 1995 ; 24:972-4.
22. Mallick NP, De Caestecker MP. The changing population ou renal replacement therapy : its clinical and economic impact in Europe. Nephrol Dial Transplant 1996 ; 11 (suppl 2):2-5.
23. Kamofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In : Evaluation of chemotherapeutic agents, Mac Leod CM ed. New York Columbia University Press, New York, 1949 ; 191-205.
24. Bommer J, Kugel M, Schwoebel B, Ritz E, Barth HP, Seelig R. Improved sexual function during recombinant human Erythropoïetin therapy. Nephrol Dial Transplant 1990 ; 5:204-7.
25. Orley J., Kuyken W. Quality of life assessment in health care settings. Springer - Verlag Heidelberg 1994
26. Spitzer WO, Dubson AJ, Hall J et al. Measuring the quality of life of cancer patients. J Chron Dis 1981 ; 34:587-97.
27. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile : development and final revision of a health-status measure. Med Care 1981 ; 19:787-805.
28. Hunt S, Mc Kenna SP, Mc Even J et al. The Nottingham health profile : subjective health status and medical consultation. Soc Sci Med 1981 ; 15 A:221-9.
29. Parfrey RS, Vavasour H, Bullock M, Henry S, Harnett JD, Gault MH. Development of a health questionnaire specific for end-stage disease. Nephron 1989 ; 52:20-8.
30. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOF) instrument. Qual Life Res 1994 ; 3:329-38.
31. Mozes B, Shabtai E. The contribution of personal rating to the clinimetric functioning of a generic Quality of Life instrument. J Clin Epid 1996 ; 49:1419-22.
32. Mc Kenna SP. Is there an European approach to quality of life measurement ? J Econ Med 1996 ; 14 (n° hors série) : 42.
33. Kutner NG, Lin NS, Fielding B, Brogan D. Hall WD. Continued survival of older hemodialysis patients : investigation of psychosocial predictors. Am J Kidney Dis 1994 ; 24:42-9.
34. Mallick NP, De Caestecker MP. The changing population ou renal replacement therapy : its clinical and economic impact in Europe. Nephrol Dial Transplant 1996 ; 11 (suppl 2):2-5.
35. Owen WF. Jr Racial différences in incidences outcome and quality of life for African-Americans on hemodialysis. Blood Purif 1996 ; 14:278-85.
36. Wai L, Richmond J, Burton H, Lindsay RM. Influence of psychosocial factors on survival of home-dialysis patients. Lancet 1981 ; ii:1155-6.
37. Roberts JC, Kjellstrand CM. Choosing death. Withdrawal from chronic dialysis without medical reasons. Acta Med Scan 1988 ; 223:181-6.
38. Paganini EP. In search of an optimal hematocrit level in dialysis patients: rehabilitation and quality of life implication. Am J Kidney Dis 1994 ; 24 (suppl 1): 10-6.
39. Kurtin P, Nissenson AR. Variation in end-stage renal disease patient outcome : what we know, what should we know and how do we find in out ? J Am Soc Nephrol 1993 ; 3:1738-47.
40. Majnoni d'Intignano B. Santé mon cher souci. J Cl Lattes, Paris 1989, 202-12.
41. Binik YM, Devins GM, Barre PE et al. Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis 1993 ; 181:371-6.
42. Maiorca R, Cancarini GC, Zubani R, Movilli E, Brunory G. Differing dialysis treatment strategies and outcome Nephrol Dial Transplant 1996 ; 11 (suppl 2): 134-9.
43. Husebye DG, Westlie L, Styrvoky TJ, Kjellstrand CM. Psychological social and somatic prognostic indicators in old patients undergoing long-term dialysis. Arch Intern Med 1987 ; 147: 1921-4.
44. Mignon F, Michel C, Viron B, Mentre F, Jaar B. End-stage renal diseases in patients 75 and over: a new medical, socio-economic and ethical challenge. Eur J Med 1992 ; 1:302-7.
45. Ismail N. Renal replacement therapy in the elderly: an old problem with young solutions. Nephrol Dial Transplant 1997 ; 12:873-6.
46. Neu S, Kjellstrand CM. Stopping long-term dialysis : an empirical study of withdrawal of life-supporting treatment. N Engl J Med 1996 ; 314:14-20.
47. Bajwa K, Szabo E, Kjellstrand CM. A prospective study in discontinuation of dialysis. Arch Intern Med 1996 ; 156:2571-7.
48. Kutner NG, Braun Curtin R, Oberley F, Sacksteder P. Fulfulling the promise: linking rehabilitation interventions with ESRD patient outcomes. Dial Transplant 1997 ; 26:282-92.
49. Wilson IB, Cleary PD. Linking clinical variables with helath-related quality of life. JAMA 1995 ; 273:59-65.
50. 10, 1989, 6p.